STOCK TITAN

VisionWave Holdings (NASDAQ: VWAV) inks $15M convertible deal with warrants

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

VisionWave Holdings, Inc. agreed with YA II PN, Ltd. to issue up to $15,000,000 in convertible debentures, sold at 85% of principal in two tranches. A $10,000,000 first tranche closed on July 20, 2026, with a $5,000,000 second tranche contingent on effectiveness of a resale registration statement. Net proceeds are earmarked for working capital and general corporate purposes.

The debentures bear 5.00% annual interest, rising to 18.00% upon default, and mature on July 20, 2027. Beginning December 30, 2026, VisionWave must make monthly principal installments of $1,750,000 plus a 2% premium and accrued interest, payable in cash or via offsets against advances under an existing Standby Equity Purchase Agreement. The debentures are convertible at the Investor’s option at $5.00 per share, with default-period conversions permitted at 90% of the lowest recent VWAP, subject to a $0.702 floor, a 4.99% beneficial ownership cap, and Nasdaq exchange-cap limits unless stockholders approve additional issuances.

In connection with this financing, VisionWave issued 1,800,000 warrants at a $5.00 exercise price, granted registration rights, and obtained guarantees from key subsidiaries. Existing noteholders of $6,000,000 and $10,000,000 promissory notes agreed to defer cash payments, and the Investor extended the maturity of $3,000,000 and $2,000,000 SEPA-related notes to January 25, 2027.

Positive

  • None.

Negative

  • None.

Filing Explained

The completed first closing adds debt obligations and a route to additional shares; resale registration and the second tranche remain unfinished milestones.

The July 21 8-K confirms that VisionWave completed the first closing of the convertible-debt financing, but the $5,000,000 second tranche remains contingent on effectiveness of the initial resale-registration statement; it does not report issuance of the underlying conversion or warrant shares.

Registration rights do not mean the resale registration is already effective: the company agreed to file an initial statement within 60 days and seek effectiveness under the agreement. The warrants were issued and are exercisable for up to 1,800,000 shares at $5.00, while debenture shares remain issuable upon investor conversion; if issued, additional shares increase the total share count and reduce existing percentage ownership absent offsetting changes. The first tranche was purchased at 85% of principal, with a $50,000 fee netted from proceeds.

The two noteholders agreed not to demand cash or exercise default remedies until the debentures are indefeasibly paid, and consented to repayment through shares. As a historical liquidity reference, cash of $15,723 at March 31, 2026 equaled 0.4 days of the last reported quarterly operating cash use.

The material next milestone is effectiveness of the initial resale-registration statement, which also conditions the second tranche; the filing does not state that either milestone has occurred.

Sources and calculations
  • Cash and equivalents vs quarterly operating cash outflow, in days of cash use $15,723 / ($3,383,428 / 90) = [object Object]
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Convertible debentures principal $15,000,000 Aggregate principal amount available under the Securities Purchase Agreement
First tranche principal $10,000,000 Principal amount of first tranche that closed on July 20, 2026
Second tranche principal $5,000,000 Principal amount of second tranche subject to registration effectiveness
Interest rate 5.00% per annum Base interest rate on the Convertible Debentures
Default interest rate 18.00% per annum Interest rate during the continuance of an event of default
Monthly principal installment $1,750,000 Scheduled monthly principal payments beginning December 30, 2026
Conversion price $5.00 per share Fixed conversion price of debentures into common stock
Warrants issued 1,800,000 shares at $5.00 Number of warrant shares and exercise price granted to the Investor
Convertible Debentures financial
"issue and sell to the Investor convertible debentures in the aggregate principal amount"
Convertible debentures are loans a company issues that pay interest like a bond but can be swapped later for the company’s shares at a set price. For investors they act like a safety-net plus a shortcut: you get regular interest payments while retaining the option to join ownership if the share price rises, which offers upside potential but can dilute existing shareholders if conversion occurs.
Standby Equity Purchase Agreement financial
"offset against the proceeds of one or more advances under the Company’s Standby Equity Purchase Agreement"
A standby equity purchase agreement is a contract in which an investor or group agrees to buy a company’s newly issued shares on demand, giving the company a ready source of cash it can tap when needed. Think of it like a line of credit made with stock instead of a loan: it provides financial backup but can increase the number of shares outstanding, diluting existing owners and affecting per‑share value, so investors watch these deals for their impact on ownership and earnings per share.
Registration Rights Agreement regulatory
"entered into a Registration Rights Agreement with the Investor"
A registration rights agreement is a contract that gives investors the option to have their ownership stakes officially registered with the government, making it easier to sell their shares later. This agreement matters because it provides investors with a clearer path to cash out their investments if they choose, offering more liquidity and confidence in their ability to sell their holdings when desired.
Exchange Cap regulatory
"exceed the aggregate number of shares of Common Stock that the Company may issue under the applicable rules"
Global Guaranty Agreement financial
"entered into a Global Guaranty Agreement in favor of the Investor"
cashless basis financial
"the Warrants may be exercised on a cashless basis"
An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What financing did VisionWave Holdings (VWAV) enter into on July 20, 2026?

VisionWave entered a Securities Purchase Agreement with YA II PN, Ltd. for up to $15,000,000 of convertible debentures, sold at 85% of principal in two tranches. A $10,000,000 first tranche closed immediately; a $5,000,000 second tranche depends on a resale registration statement becoming effective.

What are the key terms of the VWAV convertible debentures?

The debentures bear 5.00% annual interest, increasing to 18.00% on default, and mature July 20, 2027. Starting December 30, 2026, VisionWave must repay $1,750,000 of principal monthly plus a 2% premium and accrued interest, and the Investor can convert principal at $5.00 per share.

How do the conversion price and ownership limits work for VWAV’s debentures and warrants?

The Investor may convert debentures at $5.00 per share, or during defaults at 90% of the lowest 10-day VWAP, with a $0.702 floor. Conversions and warrant exercises are capped so the Investor cannot exceed 4.99% ownership or Nasdaq’s Exchange Cap without stockholder approval.

What warrants did VisionWave Holdings (VWAV) issue with this transaction?

VisionWave issued warrants to YA II PN, Ltd. to purchase up to 1,800,000 shares of common stock at an exercise price of $5.00 per share. The warrants are immediately exercisable, expire 36 months after issuance, and may be exercised on a cashless basis if resale registration is unavailable after six months.

How were existing Dream America and Adrian promissory notes affected for VWAV?

Holders of a $6,000,000 Dream America note and a $10,000,000 Adrian note agreed not to demand or accept cash payments while the debentures remain outstanding. They also agreed to forbear exercising default remedies, except as otherwise consented in writing by the new Investor.
false 0002038439 0002038439 2026-07-20 2026-07-20 0002038439 VWAV:CommonStockParValue0.01PerShareMember 2026-07-20 2026-07-20 0002038439 VWAV:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50Member 2026-07-20 2026-07-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 20, 2026

 

VisionWave Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware 001-72741 99-5002777

(State or other jurisdiction
of incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

 

300 Delaware Ave., Suite 210 # 301

Wilmington, DE 19801

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (302) 305-4790

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, par value $0.01 per share VWAV The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 VWAVW The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

Securities Purchase Agreement and Convertible Debentures

 

On July 20, 2026, VisionWave Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with YA II PN, Ltd. (the “Investor”), an investment fund managed by Yorkville Advisors Global, LP, pursuant to which the Company agreed to issue and sell to the Investor convertible debentures in the aggregate principal amount of up to $15,000,000 (the “Convertible Debentures”), at a purchase price equal to 85% of the principal amount thereof, in two tranches. The first tranche, in the principal amount of $10,000,000, closed on July 20, 2026 (the “First Closing”). The second tranche, in the principal amount of $5,000,000, will close upon the effectiveness of the initial registration statement described below under “Registration Rights Agreement.” The Company also paid the Investor a non-refundable due diligence fee of $50,000, which was netted from the proceeds of the First Closing. The Company intends to use the net proceeds of the offering for working capital and general corporate purposes.

 

The Convertible Debentures bear interest at a rate of 5.00% per annum (which increases to 18.00% per annum during the continuance of an event of default), calculated on the basis of a 365-day year, and mature on July 20, 2027. Beginning on December 30, 2026, and on the same day of each calendar month thereafter, the Company is required to repay the Convertible Debentures in monthly installments of $1,750,000 of principal, plus a payment premium equal to 2% of the principal amount being paid and accrued and unpaid interest. Installment amounts are payable, at the Company’s option, in cash or by offset against the proceeds of one or more advances under the Company’s Standby Equity Purchase Agreement with the Investor, dated July 25, 2025, as amended (the “SEPA”). While the Convertible Debentures are outstanding, any advances under the SEPA must use the three-day pricing option provided for therein, and payments in excess of the installment amount then due are not subject to the payment premium. The Company may redeem amounts outstanding under the Convertible Debentures prior to maturity at any time upon advance notice by paying the principal amount being redeemed, a redemption premium equal to 5% of such principal amount, and accrued and unpaid interest.

 

The Convertible Debentures are convertible at the option of the Investor into shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a fixed conversion price of $5.00 per share. Upon the occurrence and during the continuance of an event of default, the Investor may convert at the lower of such fixed price or a variable price equal to 90% of the lowest daily volume-weighted average price of the Common Stock during the ten trading days immediately preceding the conversion date, subject to a floor price of $0.702 per share. The Investor may not convert the Convertible Debentures (or exercise the Warrants described below) to the extent that, after giving effect thereto, the Investor and its affiliates would beneficially own more than 4.99% of the outstanding Common Stock. The Convertible Debentures also may not be converted, and the Warrants may not be exercised, to the extent the shares issuable would exceed the aggregate number of shares of Common Stock that the Company may issue under the applicable rules of The Nasdaq Stock Market LLC (the “Exchange Cap”), unless the Company’s stockholders approve issuances in excess of the Exchange Cap.

 

The Securities Purchase Agreement contains customary representations, warranties and covenants of the Company, including, among other things, covenants that, while the Convertible Debentures are outstanding and subject to specified exceptions, restrict the Company’s ability to enter into variable rate transactions (other than pursuant to the SEPA), incur additional indebtedness or grant liens, effect discounted offerings, and make payments on certain related-party indebtedness. Closing of the transaction was conditioned upon, among other things, the delivery of consent and deferral agreements by the holders of certain outstanding promissory notes issued by the Company.

 

Warrants

 

In connection with the Securities Purchase Agreement, the Company issued to the Investor warrants (the “Warrants”) to purchase up to 1,800,000 shares of Common Stock at an exercise price of $5.00 per share. The Warrants are exercisable upon issuance and expire 36 months after the date of issuance. The Warrants are exercisable for cash, provided that if, after the six-month anniversary of the date of the Securities Purchase Agreement, a registration statement covering the resale of the shares underlying the Warrants is not available, the Warrants may be exercised on a cashless basis.

 

 

 

Registration Rights Agreement

 

In connection with the Securities Purchase Agreement, the Company entered into a Registration Rights Agreement with the Investor (the “Registration Rights Agreement”), pursuant to which the Company agreed to file with the Securities and Exchange Commission (the “SEC”) an initial registration statement covering the resale of the shares of Common Stock issuable upon conversion of the Convertible Debentures and exercise of the Warrants, together with certain additional shares issuable under the SEPA, within 60 days, and to use commercially reasonable efforts to cause such registration statement to be declared effective within the deadlines specified therein and to maintain its effectiveness until the registrable securities have been sold or may be sold without restriction under Rule 144.

 

Global Guaranty Agreement

 

In connection with the Securities Purchase Agreement, certain subsidiaries of the Company receiving proceeds of the Convertible Debentures, consisting of VisionWave Technologies, Inc., VisionWave Holdings UK Ltd and Solar Drone Ltd., entered into a Global Guaranty Agreement in favor of the Investor (the “Guaranty”), pursuant to which such subsidiaries, jointly and severally, guaranteed the payment obligations of the Company under the Convertible Debentures and the related transaction documents.

 

Consent and Deferral Letter Agreements

 

On July 20, 2026, as a condition to the First Closing, the Company entered into side letter agreements (the “Consent and Deferral Letters”) with each of Dream America Marketing Services, Ltda. (“Dream America”), the holder of a promissory note issued by the Company on April 10, 2026 in the original principal amount of $6,000,000, and Adrian Holdings S.R.L. (“Adrian”), the holder of a promissory note issued by the Company on January 5, 2026 in the original principal amount of $10,000,000. Pursuant to the Consent and Deferral Letters, each of Dream America and Adrian has agreed, until the obligations under the Convertible Debentures have been indefeasibly paid in full, (i) not to demand, request, accept, receive or apply any cash payments from the Company in respect of its promissory note (including payments of principal, interest, fees, default interest, premiums, costs or expenses), with any such payments received to be returned to the Company or held in suspense unless otherwise consented to in writing by the Investor, and (ii) to forbear from exercising its rights and remedies upon the occurrence of any default under its promissory note. Each of Dream America and Adrian has also consented to the Company’s incurrence of the indebtedness under the Convertible Debentures and to the payments required to be made thereunder, whether made in cash or through the issuance and sale of shares of Common Stock and the use of the proceeds of such issuances and sales to repay the Convertible Debentures. Except as set forth in the Consent and Deferral Letters, the terms of such promissory notes remain in full force and effect.

 

Extension of Maturity of SEPA Promissory Notes

 

On July 20, 2026, the Investor, as holder of the promissory notes issued by the Company in connection with prepaid advances under the SEPA on July 25, 2025 (in the original principal amount of $3,000,000) and September 11, 2025 (in the original principal amount of $2,000,000) (collectively, the “SEPA Notes”), delivered to the Company written notice of its election, pursuant to the terms of the SEPA Notes, to extend the maturity date of the SEPA Notes to January 25, 2027 (the “Maturity Extension”), which extension the Company acknowledged and agreed.

 

The foregoing descriptions of the Securities Purchase Agreement, the Convertible Debentures, the Warrants, the Registration Rights Agreement, the Guaranty, the Consent and Deferral Letters and the Maturity Extension do not purport to be complete and are qualified in their entirety by reference to the full text of such documents, copies of which are filed as Exhibits 10.1, 4.1, 4.2, 10.2, 10.3, 10.4, 10.5 and 10.6, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.

 

 

 

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

 

Item 3.02. Unregistered Sales of Equity Securities.

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. The Convertible Debentures and the Warrants were, and the shares of Common Stock issuable upon conversion or exercise thereof will be, offered and sold to the Investor, an “accredited investor” (as defined in Rule 501(a) of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”)), in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder, without any form of general solicitation or general advertising. Such securities have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the second closing of the Convertible Debentures, the filing and effectiveness of the registration statement, and the intended use of proceeds. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including, but not limited to, the satisfaction of the conditions to the second closing, the timing of SEC review, market conditions, and the other risks described in the Company’s filings with the SEC. All forward-looking statements speak only as of the date of this Current Report, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No. Description
4.1 Form of Convertible Debenture
4.2 Form of Warrant to Purchase Common Shares
10.1 Securities Purchase Agreement, dated July 20, 2026, between VisionWave Holdings, Inc. and YA II PN, Ltd.
10.2 Registration Rights Agreement, dated July 20, 2026, between VisionWave Holdings, Inc. and YA II PN, Ltd.
10.3 Global Guaranty Agreement, dated July 20, 2026, by VisionWave Technologies, Inc., VisionWave Holdings UK Ltd and Solar Drone Ltd. in favor of YA II PN, Ltd.
10.4 Consent and Deferral Letter Agreement, dated July 20, 2026, between VisionWave Holdings, Inc. and Dream America Marketing Services, Ltda.
10.5 Consent and Deferral Letter Agreement, dated July 20, 2026, between VisionWave Holdings, Inc. and Adrian Holdings S.R.L.
10.6 Letter Agreement regarding Extension of Maturity Date, dated July 20, 2026, between VisionWave Holdings, Inc. and YA II PN, Ltd.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURES

  

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 21, 2026  
   
VISIONWAVE HOLDINGS, INC.  
   
By: /s/ Douglas Davis  
Name: Douglas Davis  
Title: Chief Executive Officer  

 

 

Filing Exhibits & Attachments

12 documents